SEMEN ALLOANTIGENS AND LYMPHOCYTOTOXIC ANTIBODIES IN AIDS AND ICL

Citation
Rs. Rootbernstein et Sh. Dewitt, SEMEN ALLOANTIGENS AND LYMPHOCYTOTOXIC ANTIBODIES IN AIDS AND ICL, Genetica, 95(1-3), 1995, pp. 133-156
Citations number
144
Categorie Soggetti
Genetics & Heredity
Journal title
ISSN journal
00166707
Volume
95
Issue
1-3
Year of publication
1995
Pages
133 - 156
Database
ISI
SICI code
0016-6707(1995)95:1-3<133:SAALAI>2.0.ZU;2-H
Abstract
More than 90% of people with AIDS develop circulating immune complexes (CICs) and lymphocytotoxic antibodies (LCTAs). Animals infected with HIV, however, never display CICs or LCTAs, and remain healthy. Similar ly, HIV-infected people who do not develop CICs or LCTAs also do not p rogress to AIDS. The appearance of CICs and LCTAs is, however, highly prognostic for AIDS and death. Since HIV infection does not, per se, l ead to the development of CICs and LCTAs, other causes are likely. One such cause, for which both epidemiologic and experimental evidence ex ists, is semen. Semen components include sperm, seminal fluid, lymphoc ytes, and sometimes infectious agents, including HIV, mycoplasmas, and herpes and hepatitis viruses, all of which independently cause immune suppression. Extensive evidence demonstrates sperm (and various virus es) contains many proteins mimicking the CD4 protein of T-helper cells , while HIV, mycoplasmas, and seminal fluid mimic class II MHC protein s of other lymphocytes. We identify a large number of protein sequence s that display such mimicry using computer homology searching, and dem onstrate experimentally that sperm antibodies specifically precipitate antibodies against class II MHC mimics such as mycoplasmas, which in turn precipitate antibodies to lymphocyte antigens. These data prove t hat immunologic exposure to sperm and lymphocytes (as may occur in rec eptive anal intercourse, needle sharing, or blood transfusions) is the oretically capable of initiating lymphocytotoxic autoimmunity. Such au toimmunity may play a significant role in the pathogenesis of AIDS, an d will need to be addressed clinically in high risk individuals regard less of HIV status and regardless of the success of anti-HIV prophylax is and treatment.